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Background: To compare the frequency of pain 
relief between corticosteroid injection combined 
with casting and casting alone in management of de 
Quervain tenosynovitis.  
Methods: Seventy patients with de Quervain's 
Tenosynovitis in age ranging from 18 to 70 years 
were recruited for the study. Two groups each 
containing 35 patients were formed by dividing the 
patients randomly. Group A was given injection 
triamcinolone with thumb spica cast and group B 
was given thumb spica cast alone. The VAS pain 
score at presentation was recorded for each patient. 
Both groups were compared regarding pain relief by 
recording VAS pain score at 4 weeks after 
presentation. The results were analyzed with the 
help of  SPSS version 10. A p value of 0.05 was 
considered significant. 
Results: Mean/average age of the patients was 
43.79±16.015 years (mean ± SD). In both groups, there 
was no statistically significant difference for the age 
and pre-treatment VAS pain score (p values 0.464 
and 0.482 respectively). In group A (Corticosteroid 
injection plus thumb spica cast) there were more 
patients which were pain free at the end of the study 
(88.5% in group A, 62.9 % in group B, p value 0.012). 
Conclusion:  Corticosteroid Injection plus thumb 
spica cast is more effective for reducing pain in de 
Quervain's Tenosynovitis as compared to thumb 
spica cast alone. 
Key Words: De Quervain's Tenosynovitis, 
corticosteroid injection, thumb spica cast. 
 
Introduction 
De Quervain, a Swiss surgeon, first defined stenosing 
tenosynovitis at the first dorsal compartment of the 
wrist in 1895.1 It occurs usually in adults 30 to 50 years 
old. Incidence in women is ten times more as 
compared to men. It  affects the extensor pollicis brevis 
(EPB) and abductor pollicis longus (APL) tendon 
sheaths.2 It is mostly caused by excessive use or an 
increase in repetitive activity. It results in  micro 
trauma from repetitive gliding of the first dorsal 
compartment tendons under the sheath of the first 
compartment over the styloid of the radius, which 
leads to thickening of the extensor retinaculum of the 
wrist. Later on, the condition was found to represent 
tendinosis as opposed to tendinitis owing to absence of 
evidence of any inflammation in histopathological 
specimens.  It occurs typically in adults ranging from 
30 to 50 years old and women are more at risk. 
Women are affected six to ten times more frequently 
than men. 2-9  It is usually caused by overuse or an 
increase in repetitive activity, Bringing about shear 
micro trauma from repetitive gliding of the first dorsal 
compartment tendons (abductor pollicis longus or 
APL, and extensor pollicis brevis or EPB) under the 
sheath of the first compartment over the styloid of the 
radius prompting thickening of the extensor 
retinaculum of the wrist.10,11  Symptoms comprise of 
pain or tenderness at the radial styloid at times 
radiating to the thumb, shoulder or forearm.On 
physical examination there might be swelling at the 
radial styloid with tenderness and crepitations on 
palpation.12,13 
For diagnosis Finkelstein’s test is done. Diagnosis is 
usually concluded by a positive test result.14 
Finkelstein's test (deviating the wrist to the ulnar side, 
while grasping the thumb, results in pain) is positive 
in typical cases.15,16 Non-surgical treatment, 
comprising of local corticosteroid injections, bracing, 
physical therapy, and thumb spica cast, is mostly 
rewarding.17 Surgery is performed in resistant cases to 
release the first dorsal compartment of the wrist.18 
There is no accord on the best protocol for wrist 
immobilization. Some authors advocate full-time 
splint or cast application for four to six weeks, with the 
justification that tendonitis will resolve with strict rest. 
Some studies showed that an general success rate for a 
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thumb spica cast plus corticosteroid injection was 87% 
and for thumb spica cast alone was 36%.19 However, 
some studies have compared the efficacy of thumb 
spica cast plus  corticosteroid injection versus 
corticosteroid injection.20   
 
Patients and Methods 
After the approval from ethical committee of the 
Rawalpindi Medical University , the data collection 
was started. Patients were diagnosed after history and 
physical examination and included in the study by 
fulfilling the inclusion criteria.  After discussing risk 
and benefits of the treatment modalities with the 
patients, their consent was taken and only those were 
included in the study who gave written informed 
consent. Patients were randomly selected by lottery 
method and equally distributed to two groups.  Group 
A (n=35) received injection triamcinolone and thumb 
spica cast. Group B (n=35) was applied only thumb 
spica cast. 
The patients in Group A were given One ml (10mg) of 
triamcinolone acetonide and 1 ml of 1% lidocaine 
hydrochloride mixed in 5 cc syringe with 25 gauge 
needle at the site of maximum tenderness and thumb 
spica cast was applied after VAS scoring. The patients 
in Group B were given only thumb spica cast after 
recording their VAS score. Both group’s casts were 
removed at three weeks and gentle physiotherapy was 
started. Both the patients were assessed at four weeks 
meanwhile discouraging them to use any painkiller. 
They were assessed through VAS score.The VAS 
scores were compared for both pre and post treatment 
at four weeks interval and pain relief was assessed.  
Mean and Standard Deviation were calculated of pain 
score and age. Comparison of pain relief at 4 weeks 
interval after treatment in both groups was done. 
Effect modifiers like age and gender were controlled 
by stratification. Post stratification Chi-Square test was 
applied and a p value of ≤0.05 was considered 
significant.  
Results  
Mean age of patients was 43.79±16.015.Mean VAS at 
presentation was 83.99±8.927, while in group A the 
mean pre-treatment VAS was 83.23±8.207, while in 
Group B the pre-treatment VAS was 84.74±9.654 
.There was no significant difference between the pre-
treatment VAS between the two groups (p=0.482). The 
mean pre-treatment VAS of male patients was 
85.33±8.751, while that of female patients was 
82.98±9.034, there was no significant difference 
between the pre-treatment VAS between the two 
genders (p=0.277). After 4 weeks the VAS of the 
patients was reassessed, recorded and analyzed. The 
mean VAS post-treatment was 27.39 ±11.540. In Group 
A, the mean VAS post-treatment was 24.51±8.480, 
while in Group B, the mean VAS post-treatment was 
30.26±13.467 (Table 1). In Group A, 88.57% (31/35) 
patients were found to be pain free, while in Group B 
62.86% (22/35) were pain free. Chi-square test was 
applied and the difference of pain relief between the 
two groups was found to be statistically significant (p= 
0.012) (Table 2).Effect modifiers like age and gender 
were controlled by stratification. Post-stratification chi-
square test was applied.Patients were stratified into 3 
groups based on their age. The 3 groups were 
compared and p-values were calculated for each 
group. Group 1 had patients between the ages of 18 
and 35 years and the p-value was 0.006. Group 2 had 
patients between the ages of 35 and 55 years and the p-
value was 0.097. Group 3 had patients between the 
ages of 55-70 years and the p-value was 0.899 (Table 
30. Stratification was also done based on gender of the 
patients and the results were compared. 14 of the 15 
male patients in group A reported being free from 
pain at 4 weeks (p=0.013), while 17 of the 20 female 
patients in group A reported being free from pain 
(p=0.256) (Table 4&5). 
Table 1. Pain score comparison among  
groups at 4 weeks 
 VAS at 4 weeks p- Value 
Group A 24.51±8.480  
0.036 Group B 30.26±13.467 
 Table 2: Comparison of pain relief  
between groups. 
 Pain Relief p- Value 
 Yes No  
0.012 Group A 31 4 
Group B 22 13 
Table 3:Comparison of pain relief between 
different age groups 
Age Group 
(years) 
Group A Group B p-value  
 Yes No Yes No  
18-35 15 0 7 5 0.06 
36-55 10 1 6 4 0.097 
56-70 6 3 9 4 0.899 
Table 4.Comparison of pain relief  
between Male patients. 
 Pain Relief p- Value 
 Yes No  
0.013 Group A 14 1 
Group B 8 7 
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Table 5. Comparison of pain relief  
between Female patients 
 Pain Relief p- Value 
 Yes No  
0.256 Group A 17 3 
Group B 14 6 
 
Discussion  
De Quervain's Tenosynovitis, although a seemingly 
insignificant condition, is very serious disorder for the 
patient as it hinders the performance of the basic 
function of the hand, the use of the thumb.13 Various 
methods of treatment for De Quervain's Tenosynovitis 
have been advised over the years including analgesics, 
splinting, multiple corticosteroid injections and 
surgical release, but the cost effective of all the options 
is a thumb spica cast, Intralesional corticosteroid 
injection is the most effective with cure rates of upto 
50% .The combination of these two treatment 
modalities gives the best outcome with immobilization 
by the cast and anti-inflammatory action by the 
steroid. The results of the combination of the two 
treatment is hypothesized to be much better than a 
single modality alone. This was the main purpose of 
our study to determine the efficacy of thumb spica cast 
and intra-lesional corticosteroid injection in relieving 
the pain of de Quervain's Tenosynovitis when it is 
compared with a cast alone. Sawaizumi, T., et al. 
evaluated the efficacy of triamcinolone in 36 patients. 
They injected twice with interval of 2 weeks and found 
that 90% were satisfied.13 de Quervain's tenosynovitis 
as it occurs more often in the female gender, 
particularly in the mothers who have infant children.5  
Akram, M., et al in their study of 80 patients with de 
Quervain's Tenosynovitis injected corticosteroids 
(methylprednisolone acetate) first at presentation and 
then at 2 weeks in non-responding patients. Their  
results showed that 98.75% patients were symptom 
free at 12th week, but 25% of patients showed adverse 
reactions to the steroid injections14.   
Mehdinasab S A and  Alemohammad et al, compared 
corticosteroid injection (methylprednisolone acetate) 
plus thumb spica and casting alone. Their results are 
comparable to our results as the injection group 
showed a success rate of 86.5%. The VAS pain score in 
their study also showed a very significant reduction in 
the injection group with the pre-treatment VAS score 
at 97.16±2.31 while after treatment with steroid 
injection and thumb spica cast the VAS dropped to 
6.70±6.82. The result of the cast group, in contrast to 
our results, showed a failure rate of 63.9% while our 
results showed a failure rate of 37%. This may be due 
to difference of technique in the application of the cast, 
the duration of cast application and after care of the 
cast5. Mardani-Kivi, M., et al. Their study compared 
the efficacy of corticosteroid injection with and 
without thumb spica cast. His results showed that the 
group with combination therapy had a success rate of 
93% while the group with only corticosteroid injection 
had a success rate of 69%. 20  
According to pain relief criteria, that was set at the 
beginning of the study, a VAS pain score of ≤3 after 
treatment, a total of 53 patients were considered to be 
pain free at the end of the study, while 17 patients 
were considered to be in pain. Of the 53 pain free 
patients, 31 belonged to the group that was treated 
with both the cast and steroid injection .Thus 89% of 
the patients that were given the combination treatment 
were pain free at 4 weeks, while in the other group 
who were treated with the thumb spica cast alone 13 
patients were considered to be still in pain , showing a 
success rate of 63% in this group. The difference of the 
number of patients who were pain free among the the 
two groups was statistically significant (p=0.012).  
 
Conclusion 
1. Corticosteroid injection with Thumb Spica Cast is 
more effective in reducing pain in de Quervain's 
Tenosynovitis  than Thumb Spica Cast alone.  
 
References 
1. Menendez ME, Ring D. de Quervain tendinopathy: "success" 
and other subtleties. J Hand Surg Am. 2014;39(6):1232-3. 
2. de Quervain F. On the nature and treatment of stenosing 
tendovaginitis on the styloid process of the radius. 
(Translated article: Muenchener Medizinische 
Wochenschrift 1912, 59, 5-6). J Hand Surg Br. 
2005;30(4):392-94. 
3. Ahmed GS, Tago IA, Makhdoom A. Outcome of 
corticosteroid injection in De Quervain's tenosynovitis. J 
Liaquat Uni Med Health Sci. 2013;12:30-33. 
4. Mehdinasab SA, Alemohammad SA. Methylprednisolone 
acetate injection plus casting versus casting alone for the 
treatment of de Quervain's tenosynovitis. Arch Iran Med. 
2010;13(4):270-74. 
5. Afshar A. An update on embryology of the upper limb. J 
Hand Surg Am. 2013;38(11):2304. 
6. Olubaniyi BO, Bhatnagar G, Vardhanabhuti V, Brown SE, 
Gafoor A, Suresh PS. Comprehensive musculoskeletal 
sonographic evaluation of the hand and wrist. J Ultrasound 
Med. 2013;32(6):901-14. 
7. Lee SW, Ng ZY, Fogg QA. Three-dimensional analysis of the 
palmar plate and collateral ligaments at the proximal 
interphalangeal joint. J Hand Surg Eur Vol. 2014;39(4):391-
97. 
8. Hazani R, Engineer NJ, Cooney D, Wilhelmi BJ. Anatomic 
landmarks for the first dorsal compartment. Eplasty. 
2008;8:e53. 
9. Dickson JK, Morris G, Heron M. The importance of hand 
anatomy in the accident and emergency department: 
Journal of Rawalpindi Medical College (JRMC); 2018;22(3): 236-239 
 239 
assessment of hand anatomy knowledge in doctors in 
training. J Hand Surg Eur Vol. 2009;34(5):682-84. 
10. Kulthanan T, Chareonwat B. Variations in abductor pollicis 
longus and extensor pollicis brevis tendons in the Quervain 
syndrome: a surgical and anatomical study. Scand J Plast 
Reconstr Surg Hand Surg. 2007;41(1):36-38. 
11. Petit Le Manac'h A, Roquelaure Y, Ha C, Bodin J, Meyer G, 
Bigot F, et al. Risk factors for de Quervain's disease in a 
French working population. Scand J Work Environ Health. 
2011;37(5):394-401. 
12. Huisstede BM, Coert JH, Friden J, Hoogvliet P, European HG. 
Consensus on a multidisciplinary treatment guideline for de 
Quervain disease: results from the European HANDGUIDE 
study. Phys Ther. 2014;94(8):1095-110. 
13. Stephens MB, Beutler AI, O'Connor FG. Musculoskeletal 
injections: a review of the evidence. Am Fam Physician. 
2008;78(8):971-76. 
14. Wolfe SW. Regarding "Corticosteroid injection with or 
without thumb spica cast for de Quervain tenosynovitis". J 
Hand Surg Am. 2014;39(5):1024. 
15. Boussakri H, Bouali A. Subcutaneous Rupture of the Extensor 
Pollicis Longus Tendon after Corticosteroid Injections for 
DeQuervain's Stenosing Tenovaginitis. Case Rep Orthop. 
2014;2014:934384. 
16. Becker SJ, Bot AG, Curley SE, Jupiter JB, Ring D. A 
prospective randomized comparison of neoprene vs 
thermoplast hand-based thumb spica splinting for 
trapeziometacarpal arthrosis. Osteoarthritis Cartilage. 
2013;21(5):668-75. 
17. Lee HJ, Kim PT, Aminata IW, Hong HP, Yoon JP, Jeon IH. 
Surgical release of the first extensor compartment for 
refractory de quervain's tenosynovitis: surgical findings and 
functional evaluation using DASH scores. Clin Orthop Surg. 
2014;6(4):405-09. 
18. Goel R, Abzug JM. de Quervain's tenosynovitis: a review of 
the rehabilitative options. Hand (N Y). 2015;10(1):1-5. 
19. Sawaizumi T, Nanno M, Ito H. De Quervain's disease: 
efficacy of intra-sheath triamcinolone injection. Int Orthop. 
2007;31(2):265-8. 
20. Mardani-Kivi M, Karimi Mobarakeh M, Bahrami F. 
Corticosteroid injection with or without thumb spica cast for 
de Quervain tenosynovitis. J Hand Surg Am. 2014;39(1):37-
41. 
 
